Law 360
FEBRUARY 8, 2024
The Delaware Supreme Court affirmed a Chancery Court decision ordering a medical claims management company to pay the legal fees of its ex-CEO after he was found liable for breaching his fiduciary duties.
Patently O
AUGUST 19, 2022
In order to facilitate resolution of brand-generic patent conflict, the Patent Laws include a form of paper infringement–a legal fiction that simply filing an ANDA and Paragraph IV certification counts as a form of patent infringement. Neither court decision discusses the doctrine of equivalents.). 35 U.S.C. §
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ClimateChange-ClimateLaw
MAY 12, 2023
In total, at least 25 cases have been filed in California, Colorado, Connecticut, Delaware, Hawai’i, Maryland, Minnesota, New Jersey, New York, Rhode Island, South Carolina, and Vermont. The Supreme Court sided with the fossil fuel company defendants, ruling that appellate courts could review all grounds of the remand order.
SCOTUSBlog
APRIL 20, 2022
Some older Supreme Court decisions support that theory of consent. Some courts read [Supreme Court precedent] as effectively foreclosing [this consent-by-registration theory of jurisdiction], while others insist it remains viable.”. Animal Legal Defense Fund. Animal Legal Defense Fund , 21-760. New Relists.
Conflict of Laws
MAY 17, 2023
The United States legal system is immensely complex. There are state courts and federal courts, state statutes and federal statutes, state common law and federal common law. In theory, the fact that the federal courts apply federal common law to this question should produce uniform results across the nation.
Patently O
JANUARY 3, 2024
Court of Appeals for the Federal Circuit has begun 2023 with its first precedential patent decision in DexCom, Inc. In an opinion by Judge Stoll, the court affirmed a district court decision denying DexCom’s motion for a preliminary injunction. District Court for the District of Delaware.
FDA Law Blog
SEPTEMBER 29, 2021
Despite the ongoing legal proceedings, HRSA sent letters to the drug companies on May 17, 2021 stating that their 340B restrictions violated the 340B statute and that they “must immediately begin offering its covered outpatient drugs at the 340B ceiling price to covered entities through their contract pharmacy arrangements.” Becerra , No.
Expert insights. Personalized for you.
40 
Let's personalize your content